Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.
Saved in:
| Title: | Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures. |
|---|---|
| Authors: | Ye Z; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China., Rae CL; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, United Kingdom., Nombela C; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Ham T; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Rittman T; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Jones PS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Rodríguez PV; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Coyle-Gilchrist I; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Regenthal R; Division of Clinical Pharmacology, Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany., Altena E; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Housden CR; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Maxwell H; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Sahakian BJ; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.; Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom., Barker RA; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Robbins TW; Department of Psychology, University of Cambridge, Cambridge, United Kingdom.; Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom., Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, United Kingdom.; Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom. |
| Source: | Human brain mapping [Hum Brain Mapp] 2016 Mar; Vol. 37 (3), pp. 1026-37. Date of Electronic Publication: 2016 Jan 12. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 9419065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0193 (Electronic) Linking ISSN: 10659471 NLM ISO Abbreviation: Hum Brain Mapp Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0193 |
|---|---|
| DOI: | 10.1002/hbm.23087 |
